Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > NEW!! SIX buck target.

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jan 16, 2023 9:28am

153 Views

Post# 35225321

RE:RE:NEW!! SIX buck target.

Thanks Merc. I did tell everyone to buy while you can.

Mercuryfilling1 wrote: Well, between Dougie LowBall Loe's prediction, the waning-right's $6 optimism, and Phil's uncontrolled smirking, I figure something's up. Only question is, who are they planning to throw under the bus this time 'round? If you picked up some extra play shares recently, in the mid seventies, you've done well.

stockhunter1 wrote: January 10-2023

Joseph Pantginis from H.C. Wainwright & Co. has done a fine job writing an analysis on Sernova. He is both a Ph.D and an M.S in Molecular Genetics and as such his evaluation was made with a very educated mind. His analysis was released the same day that Vertex's trial was put on hold. It makes me think our valuation may have been higher than $6 had Joseph been aware of the FDA decision to put a hold on Vertex's trial. Reports like this one and others are a culmination of many years of efforts and a testament to the future of Sernova. Enjoy the read and try to imagine the fair value of SVA (Patents,ETC) and the CELL pouch. 2023 will be a telling year. Do re-post this link as positive sentiment on all the bullboards will go along ways towards increasing our market cap before potential buyer'S step up.

https://hcwco.com/services/research/meet-our-analysts/#toggle-id-1